We are live on ! Find out more
AKAO

Achaogen Inc
AKAO

Delisted

AKAO was delisted on the 25th of April, 2019.

82 hedge funds and large institutions have $722M invested in Achaogen Inc in 2017 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 24 increasing their positions, 24 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

103% more capital invested

Capital invested by funds: $355M → $722M (+$366M)

50% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 18

21% more call options, than puts

Call options by funds: $9.04M | Put options by funds: $7.47M

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

3% more funds holding

Funds holding: 8082 (+2)

0% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 24

Holders
82
Holders Change
+2
Holders Change %
+2.5%
% of All Funds
2.04%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.17%
New
27
Increased
24
Reduced
24
Closed
18
Calls
$9.04M
Puts
$7.47M
Net Calls
+$1.58M
Net Calls Change
-$49K
Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$132M +$62 +3 +0%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$121M +$38.5M +1,871,764 +64%
BBA
3
Baker Bros. Advisors
New York
$116M
VVM
4
Versant Venture Management
California
$32.3M
PC
5
Polar Capital
United Kingdom
$32.3M -$9.64M -469,029 -27%
FCMI
6
Foresite Capital Management III
California
$31.4M -$28M -1,362,797 -52%
T. Rowe Price Associates
7
T. Rowe Price Associates
Maryland
$27.6M +$22.4M +1,092,777 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$26.9M +$2.21M +107,406 +11%
FCM
9
Farallon Capital Management
California
$20.6M +$9.6M +467,500 +134%
Point72 Asset Management
10
Point72 Asset Management
Connecticut
$14.4M -$1.79M -86,929 -13%
TCM
11
TimesSquare Capital Management
New York
$13.3M +$10.8M +526,600 New
BlackRock
12
BlackRock
New York
$12.5M +$10.1M +493,416 +23,496%
State Street
13
State Street
Massachusetts
$10.5M +$8.18M +397,988 +2,140%
SSA
14
Schonfeld Strategic Advisors
New York
$10.5M -$16.8K -819 -0.2%
Citadel Advisors
15
Citadel Advisors
Florida
$7.13M +$4.7M +229,016 +429%
IBT
16
International Biotechnology Trust
United Kingdom
$7.07M +$5.75M +280,038 New
EI
17
EAM Investors
California
$7M -$3.19M -155,148 -36%
Fiera Capital (Canada)
18
Fiera Capital (Canada)
Quebec, Canada
$6.96M +$5.67M +275,771 New
Axa
19
Axa
France
$6.64M -$98.7K -4,803 -2%
NIP
20
Nicholas Investment Partners
California
$6.26M +$1.83M +88,977 +56%
Millennium Management
21
Millennium Management
New York
$5.63M -$12.1M -588,581 -73%
SIM
22
Spark Investment Management
New York
$5.35M +$2.31M +112,400 +113%
SFM
23
Sphera Funds Management
Israel
$5.05M -$6.46M -314,342 -61%
Lord, Abbett & Co
24
Lord, Abbett & Co
New Jersey
$4.34M +$3.54M +172,154 New
Geode Capital Management
25
Geode Capital Management
Massachusetts
$4.19M +$536K +26,100 +19%

AKAO Hedge Fund Activity: Q1 2017 in Review

82 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Achaogen Inc (AKAO) for Q1 2017, worth a combined $722M — up 103% from $355M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new AKAO positions and 18 closed out — a net gain of 9 holders — while 24 added to existing stakes and 24 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $38.5M. The largest seller was Foresite Capital Management III, cutting an estimated $28M.

  • 82 institutional investors held Achaogen Inc (AKAO) as of Q1 2017, up from 80 in Q4 2016.
  • Funds reported $722M of Achaogen Inc stock for Q1 2017, up 103% quarter-over-quarter.
  • 27 funds opened new Achaogen Inc positions in Q1 2017 and 18 closed out, a net change of +9 holders.
  • The largest Achaogen Inc buyer in Q1 2017 was Fidelity Investments, an estimated $38.5M added.
  • The largest Achaogen Inc seller in Q1 2017 was Foresite Capital Management III, an estimated $28M sold.

Based on aggregated 13F filings for Q1 2017.